Tempest Therapeutics Inc Share Price Today: Live Updates & Key Insights
Tempest Therapeutics Inc share price today is $2.28, up 6.02%. The stock opened at $2.18 against the previous close of $2.16, with an intraday high of $2.3 and low of $2.13.
Tempest Therapeutics Inc Share Price Chart
Tempest Therapeutics Inc
Tempest Therapeutics Inc Share Price Performance
Tempest Therapeutics Inc Institutional Holdings
Tempest Therapeutics Inc Market Status
Tempest Therapeutics Inc Fundamentals
Market Cap 30.87 M
PB Ratio 4.6098
PE Ratio 0.0
Enterprise Value 30.68 M
Total Assets 41.49 M
Volume 294115
Tempest Therapeutics Inc Company Financials
About Tempest Therapeutics Inc & investment objective
Company Information Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its clinical-stage lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California.
Organisation Biotechnology
Employees 24
Industry Biotechnology
CEO Dr. Matthew Angel Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Tempest Therapeutics Inc FAQs
What is the share price of Tempest Therapeutics Inc today?
The current share price of Tempest Therapeutics Inc is $2.28.
Can I buy Tempest Therapeutics Inc shares in India?
Yes, Indian investors can buy Tempest Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Tempest Therapeutics Inc shares in India?
You can easily invest in Tempest Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Tempest Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Tempest Therapeutics Inc.
Can I buy fractional shares of Tempest Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Tempest Therapeutics Inc?
Tempest Therapeutics Inc has a market cap of $30.87 M.
In which sector does Tempest Therapeutics Inc belong?
Tempest Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Tempest Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Tempest Therapeutics Inc?
The PE ratio of Tempest Therapeutics Inc is N/A and the PB ratio is 4.61.